BACPHAR.BO

Compare

No price history available for this symbol yet.

Fair-value model

Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.

Years of analysisAssumption entries

Analyst estimates unavailable for this ticker.

Held by

portfolios on TandT

Bookmarked by

users

Avg position size

—

of holders' portfolios

13F filers

institutions

Sector

Medical - Pharmaceuticals

DCF fair valuemodel estimate

Intrinsic value

$1.18

Price

$20.34

Implied downside

-94%

Peer comparison

Symbol	Price	Today	Mkt cap	P/E
BACPHAR.BOBacil Pharma Limited	$20.34	+4.95%	$292M	—
ANG.BOANG Lifesciences India Limited	$36.50	+1.61%	$477M	—
BALAXI.NSBalaxi Pharmaceuticals Limited	$23.12	-1.15%	$1.3B	—
CRSTCHM.BOCrestchem Limited	$154.45	+8.39%	$463M	—
DECCAN.BODeccan Health Care Ltd	$12.07	-3.44%	$299M	—
MEDICAPQ.BOMedi-Caps Limited	$28.58	-9.98%	$356M	—
NGIND.BONG Industries Ltd.	$115.45	-0.47%	$387M	—

Source: Financial Modeling Prep · peers by sector/industry

Bacil Pharma Limited

Bacil Pharma Limited operates as a specialist in the production and distribution of a diverse range of pharmaceutical, therapeutic, and botanical goods. Their primary manufacturing facility, situated in Lote-Parshuram, is additionally equipped for the processing of herbal extracts and the synthesis of drug intermediates. The company was established on May 8, 1987, and its corporate headquarters are located in Mumbai, India.

bacilpharma.co.in

Employees: 2
IPO / List date: Jan 3, 2000
HQ: IN

Held by traders on TradeandTell

No one on the platform currently holds BACPHAR.BO.

Super investors & insiders

Institutions holding (13F)

No tracked institution reports a position in BACPHAR.BO as of their last filing.

Insider activity (SEC Form 4)

No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.

Insider activity (SEC Form 4)

Recent trades on TradeandTell

No one on the platform has traded BACPHAR.BO yet.